Results 21 to 30 of about 5,620 (124)

The CD83 Molecule – An Important Immune Checkpoint

open access: yesFrontiers in Immunology, 2020
The CD83 molecule has been identified to be expressed on numerous activated immune cells, including B and T lymphocytes, monocytes, dendritic cells, microglia, and neutrophils.
Linda Grosche   +9 more
doaj   +1 more source

Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83

open access: yesViruses, 2023
Porcine reproductive and respiratory syndrome virus (PRRSV), the most economically important infectious disease of pigs, elicits poor innate and adaptive immune responses. Soluble CD83 (sCD83), a secretion from various immune cell populations, especially
Xingyu Gong   +8 more
doaj   +1 more source

CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma

open access: yesHaematologica, 2018
Chemotherapy and hematopoietic stem cell transplantation are effective treatments for most Hodgkin lymphoma patients, however there remains a need for better tumor-specific target therapy in Hodgkin lymphoma patients with refractory or relapsed disease ...
Ziduo Li   +21 more
doaj   +1 more source

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential

open access: yesFrontiers in Immunology, 2019
CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic
Ziduo Li   +13 more
doaj   +1 more source

Soluble human CD83 ameliorates lupus in NZB/W F1 mice

open access: yesImmunobiology, 2013
In the present study we explored the immunomodulatory potential of prokaryotically expressed soluble CD83 in the treatment of murine lupus using the NZB/W F1 mouse model. Therefore female NZB/W F1 lupus mice were treated either with sCD83 or PBS for 4 weeks.
Starke, Charlotte   +3 more
openaire   +3 more sources

A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice

open access: yesFrontiers in Immunology, 2017
For the normal development of pregnancy, a balance between immune tolerance and defense is crucial. However, the mechanisms mediating such a balance are not fully understood.
Damián Oscar Muzzio   +5 more
doaj   +1 more source

Bioengineered Pancreatic Cancer Immunosuppressive Microenvironment Models for Screening Immunotherapies. [PDF]

open access: yesAdv Healthc Mater
Bioengineering tumor‐stroma pancreatic cancer models with potential to emulate the native immunosuppressive tumor microenvironment. Cancer‐on‐a‐bead models exhibited higher relevance for screening immunotherapies and modulating the protumoral PDAC microenvironment. ABSTRACT Pancreatic cancer is notably resistant to treatment, primarily due to its dense
Monteiro MV   +4 more
europepmc   +2 more sources

An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases

open access: yesFrontiers in Immunology, 2018
Many neurologic diseases are related to autoimmune dysfunction and a variety of molecules or reaction pathways are involved in the regulation of immune function of the nervous system. Soluble CD83 (sCD83) is the soluble form of CD83, a specific marker of
Li Bo, Tan Guojun, Guo Li
doaj   +1 more source

A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts [PDF]

open access: yesTransplant International, 2007
CD83 is a surface marker expressed on matured dendritic cells (DCs). It plays a pivotal role in the mediation of DC/T cell interaction and induction of T-cell activation. Previous studies have suggested that a soluble form of CD83 could suppress DC maturation and inhibit T-cell activation and, as a result, it can prevent paralysis associated with ...
Jun-Fa, Xu   +9 more
openaire   +2 more sources

Soluble CD83 inhibits acute rejection by up regulating TGF-β and IDO secretion in rat liver transplantation

open access: yesTransplant Immunology, 2021
Allogeneic transplantation immune tolerance is currently a hot research issue and soluble CD83(sCD83) is a novel immunomodulator with great potential in inducing transplantation tolerance.To investigate the mechanism of the immune tolerance effect of sCD83 on rat liver transplantation.A rat liver transplantation model was established to study the ...
Liangxing, Xiong   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy